Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.
about
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaErk regulation of actin capping and bundling by Eps8 promotes cortex tension and leader bleb-based migration.Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cellsChildren's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements.TACC3 is essential for EGF-mediated EMT in cervical cancerPediatric acute lymphoblastic leukemia: where are we going and how do we get there?Analysis of whole genomic expression profiles and screening of the key signaling pathways associated with pancreatic cancerTreatment of infant leukemias: challenge and promise.Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.TACC2 (transforming acidic coiled-coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferationEpidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transitionTumor protein D52 represents a negative regulator of ATM protein levels.FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia.Promoter-Specific Expression and Genomic Structure of IgLON Family Genes in MouseThe evolution of clinical trials for infant acute lymphoblastic leukemia.Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission.Predicting relapse risk in childhood acute lymphoblastic leukaemia.Novel oncoprotein EPS8: a new target for anticancer therapy.Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?Pharmacogenomics and the treatment of acute myeloid leukemia.Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesisMuLV-related endogenous retroviral elements and Flt3 participate in aberrant end-joining events that promote B-cell leukemogenesis.Treatment outcome of young children with acute lymphoblastic leukaemia: achievements and directions implied from Shanghai Children's Medical Centre based SCMC-ALL-2005 protocol.The IRX1/HOXA connection: insights into a novel t(4;11)- specific cancer mechanismMolecular characterization of identical, novel MLL-EPS15 translocation and individual genomic copy number alterations in monozygotic infant twins with acute lymphoblastic leukemia.Identifying new targets in leukemogenesis using computational approaches.LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19.Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities.Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia.EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.Default Patterning Produces Pan-cortical Glutamatergic and CGE/LGE-like GABAergic Neurons from Human Pluripotent Stem Cells.A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia.Unique Familial MLL(KMT2A)-Rearranged Precursor B-Cell Infant Acute Lymphoblastic Leukemia in Non-twin Siblings.Impact of mutations in FLT3, PTPN11 and RAS genes on the overall survival of pediatric B cell precursor acute lymphoblastic leukemia in Brazil.Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.Dysregulated transcriptional networks in and -rearranged T-ALLAcute lymphoblastic leukemia
P2860
Q26781328-4C6572A5-4871-4103-95F7-A97A9F580F9BQ30405419-974E6265-BD69-43CB-AF75-A78161E34C2CQ30490446-9EFED6ED-C741-44B6-8C37-81F93F5606C9Q31814868-8E74FC0D-3BF9-4BE4-A699-37BACCF83403Q33711119-3019D998-53F1-4BE8-A26F-201AB3791ED7Q34845478-7E28BB70-4853-421A-AFB8-040D2D50A91AQ34925509-6CC8FD10-E07C-46A3-AE24-8CC5A91FE2C8Q36163029-A1E1E2E7-CB5F-4073-ADA0-A9E096228316Q36196775-C8485021-D836-4BFB-B854-DA3CCE1AB03DQ36508988-95A1C8E1-E7F4-4BC0-9D8F-529292C0A08EQ36873301-01A8B83B-BB97-4E00-8742-023507CC04FAQ37148953-36AEDE87-A64A-4A29-B26A-D8CCD7475470Q37297616-4623A52E-8E3E-4B5C-91E2-62CD16E0ED49Q37420061-3828DCF8-38FE-4BE2-88B7-C1B0BC805D81Q37580317-C3EFECA9-EB8E-4742-BD7A-B7384D132CE3Q37619995-903BD00E-7BDF-4319-84A1-810B019D4AE9Q37730023-A0DA4E78-67AC-496C-9570-E5158CB1296CQ38079288-3ABF9D7B-A841-4B36-97CB-6DAF3B3D962EQ38117685-73E0247C-0E6D-4BBE-81BB-C77028DA8D73Q38150879-108934E3-6920-4BFF-9F98-33766FBC3669Q38209599-9EADE81D-9A66-4676-8E3E-B4F2D822DA9BQ38887034-E3BD7EB5-AE24-4342-84FC-705DDC40C951Q39444659-69DD253F-312E-41EB-870D-BA75137C09DEQ40553965-432E6225-55E5-4342-AB44-E09CDDE5E0BCQ41500605-89755E8C-47FF-49DB-9FD7-FB04AE60B492Q41610527-D38F4656-947E-4D99-8CBB-2C2B9A3632F1Q41890372-A52DCB43-91B0-431E-A956-50A609005449Q41903687-9DAD7E83-228F-4736-BD8B-303D95F10163Q42397452-4A90A834-F509-4AC2-A7F6-D4BB76B89276Q42923852-3B01F9F4-B13F-4EF7-B2DB-01608DF0060CQ46169481-74ED3D10-7D48-4076-9DBD-E79DC42A214EQ47142470-581D15E3-E078-4B39-A003-1A7B4868793EQ47388144-FF42CBC9-2E8E-44D4-B51A-AF9AE72E8884Q47857110-5DEA6F3C-8FED-47B5-87EA-44E7D1295BA9Q49556327-1CB9BE92-8849-4D13-94F4-66469A94EC35Q52879372-CD0131D1-B148-4332-B4FD-7B96717683B7Q54406965-D1BE5335-8650-4999-8FFB-A856A946D4D2Q54441612-0FE08373-F233-4945-A09C-7A1F85241F34Q56518873-B752B2D1-A1B0-41B8-A13C-B96D19B9852FQ58481759-88D42FB9-9698-4987-9CC8-EFA4FF70487F
P2860
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Gene expression profiles predi ...... ildren's Oncology Group study.
@ast
Gene expression profiles predi ...... ildren's Oncology Group study.
@en
type
label
Gene expression profiles predi ...... ildren's Oncology Group study.
@ast
Gene expression profiles predi ...... ildren's Oncology Group study.
@en
prefLabel
Gene expression profiles predi ...... ildren's Oncology Group study.
@ast
Gene expression profiles predi ...... ildren's Oncology Group study.
@en
P2093
P2860
P50
P1433
P1476
Gene expression profiles predi ...... ildren's Oncology Group study.
@en
P2093
Andrew J Carroll
Blaine W Robinson
Bruce Camitta
Carla S Wilson
Carolyn A Felix
Cheryl L Willman
Edward J Bedrick
Gregory H Reaman
Huining Kang
I-Ming Chen
P2860
P304
P356
10.1182/BLOOD-2011-10-382861
P407
P577
2011-12-30T00:00:00Z